Currently, there are 3.73M common shares owned by the public and among those 3.68M shares have been available to trade.
The company’s stock has a 5-day price change of -5.10% and 42.68% over the past three months. HSDT shares are trading 3.24% year to date (YTD), with the 12-month market performance down to -91.02% lower. It has a 12-month low price of $0.37 and touched a high of $9.50 over the same period. HSDT has an average intraday trading volume of 2.44 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.74%, 16.08%, and -49.77% respectively.
Institutional ownership of Helius Medical Technologies Inc (NASDAQ: HSDT) shares accounts for 2.17% of the company’s 3.73M shares outstanding.
It has a market capitalization of $2.58M and a beta (3y monthly) value of 1.47. The earnings-per-share (ttm) stands at -$6.18. Price movements for the stock have been influenced by the stock’s volatility, which stands at 13.85% over the week and 21.33% over the month.
Analysts forecast that Helius Medical Technologies Inc (HSDT) will achieve an EPS of -0.94 for the current quarter, -0.92 for the next quarter and -2.5 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.94 while analysts give the company a high EPS estimate of -0.94. Earnings per share for the fiscal year are expected to increase by 61.26%, and 55.67% over the next financial year.
Looking at the support for the HSDT, a number of firms have released research notes about the stock. Noble Capital Markets stated their Outperform rating for the stock in a research note on March 24, 2021, with the firm’s price target at $20.
